Meyka AI API is live for developers.Start building.
Advertisement
Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIV) Stock Overview

Explore Roivant Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

ROIV●NASDAQ
HealthcareBiotechnology
$34.01
$1.80(5.59%)
U.S. Market opens in 7h 45m
Advertisement

Roivant Sciences Ltd. (ROIV)

Meyka AI Score

Z

Key Financials

Market Cap24.5B
P/E Ratio-75.13
EPS (TTM)$-0.54
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$28.28
3 Months$35.52
1 Year Target$33.96

ROIV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roivant Sciences Ltd. (ROIV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.44, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $33.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -75.13 and a market capitalization of 24.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.59%
5-Day Change
7.49%
1-Month Change
13.52%
3-Month Change
26.57%
6-Month Change
51.16%
Year-to-Date (YTD) Change
56.73%
1-Year Change
194.71%
3-Year Change
270.48%
5-Year Change
243.88%
All-Time (Max) Change
227.02%

Contact Information

https://roivant.com
44 2074 003 347
11-12 St. James's Square, London, NaN, SW1Y 4LB

Company Facts

9,080 Employees
IPO DateDec 8, 2020
CountryGB
Actively Trading

Frequently Asked Questions